YAP1 and metabolic dysfunction-associated steatotic liver disease: Rosmarinic acid (RA) also downregulates YAP protein levels and ameliorates NAFLD by modulating the YAP/TAZ–PPARγ/proliferator-activated receptor γ coactivator-1α (PGC-1α) signaling pathway [153].